Zimvie INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$41Mgeneral payments (2019-2025)
$260Kresearch payments (2019-2025)
31,140clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $16M
2023 $16M
2024 $5.6M
2025 $3.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery of The Spine $13M
Orthopaedic Surgery $6.5M
General Practice (Dentist) $6.2M
Dentist $5.1M
Neurological Surgery $3.1M
Prosthodontics $2.6M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Roger Jackson North Kansas City, MO Orthopaedic Surgery of The Spine $8,489,109.81
Mark Barry Las Vegas, NV Orthopaedic Surgery $1,650,095.95
Amer Samdani Philadelphia, PA Neurological Surgery $1,325,734.69
Bradford Currier Rochester, MN Orthopaedic Surgery $988,231.59
Michael Vitale New York, NY Orthopaedic Surgery $856,953.07
David Skaggs Los Angeles, CA Orthopaedic Surgery $803,139.51
Bruce Ouellette West Palm Beach, FL General Practice (Dentist) $619,535.56
John Braun Waterbury Center, VT Orthopaedic Surgery of The Spine $599,490.16
Clifford Tribus Madison, WI Orthopaedic Surgery $567,212.10
Frank Schwab New York, NY Orthopaedic Surgery of The Spine $558,460.25

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.